Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Pre- and Post-Treatment Serum Levels of Cytokines IL-1β, IL-6, and IL-1 Receptor Antagonist in Celiac Disease. Are They Related to the Associated Osteopenia?

Fornari, Cecilia M, MD; Pedreira, Silvia, MD; Niveloni, Sonia, MD; González, Diana, MD; Diez, Roberto A, MD; Vázquez, Horacio, MD; Mazure, Roberto, MD; Sugai, Emilia, PhD; Smecuol, Edgardo, MD; Boerr, Luis, MD; Mauriño, Eduardo, MD; Bai, Julio C, MD*

American Journal of Gastroenterology: March 1998 - Volume 93 - Issue 3 - p 413–418
doi: 10.1111/j.1572-0241.1998.00413.x

Objective: Decreased bone mineral density is a common finding in untreated celiac disease patients. However, the precise pathophysiology of osteopenia remains incompletely understood. Pathological features of gluten sensitivity are associated with local release of proinflammatory and antiinflammatory cytokines. We investigated the serum levels of IL-1β, IL-6, and IL-1 receptor antagonist in celiac patients and correlated them with bone density measurements.

Methods: We assessed serum samples of 16 female patients at the time of diagnosis (on an unrestricted diet) and after a mean time of 37 months on a gluten-free diet. At the same time, bone mineral density in the lumbar spine and total skeleton was determined by DEXA.

Results: Untreated patients had high serum levels of IL-1β and IL-6 and normal IL-1-RA. Treatment produced a decrease in median IL-1β levels (p = NS) and a significant diminution of IL-6 (p < 0.05). On the contrary, IL-1-RA increased significantly after treatment (p < 0.05). Baseline lumbar spine Z-score and IL-6 levels exhibited a significant inverse correlation (r =–0.61; p < 0.01). Patients with more severe baseline osteopenia (< -2 Z-scores) had a significantly lower IL-1-RA than those with less bone compromise (> -2 Z-scores).

Conclusions: Our data demonstrate that the inflammatory process observed in active celiac disease is associated with high serum levels of IL-1β and IL-6 and normal levels of IL-1-RA. Treatment significantly reduces both proinflammatory cytokines and significantly increases the antiinflammatory one. We also suggest that these cytokines might have a role in the osteopenia associated with celiac disease.

Sectión Intestine Delgado, Servicio de Clínica, Departamento de Medicina, Hospital de Gastroenterología Dr Carlos Bonorino Udaondo; Universidad del Salvador, Labomtorio de Inmunofarmacología, Facultad de Medicina (UBA); and Centro de Osteopatías Médicas y Reumatología, Hospital de Clínicas (UBA), Buenos Aires, Argentina

*Hospital de Gastroenterología Dr Carlos Bonorino Udaondo, Gaseros 2061, 1246 Buenos Aires, Argentina.

© The American College of Gastroenterology 1998. All Rights Reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website